Mediterranean Diet May Modestly Reduce Risk for Obesity-Related Cancers
THURSDAY, Feb. 27, 2025 -- Higher adherence to the Mediterranean diet (MedDiet) is associated with a modest reduction in the risk for obesity-related cancers (ORCs), according to a study published online Feb. 25 in JAMA Network Open.
Inmaculada Aguilera-Buenosvinos, Ph.D., from the University of Navarra in Spain, and colleagues examined the association between adherence to the MedDiet and the risk for ORCs. The analysis included data from 450,111 participants (mean age, 51.1 years) in the European Prospective Investigation Into Cancer and Nutrition study.
The researchers found that during a median 14.9 years of follow-up, 4.9 percent of participants experienced an ORC (rates, 0.053, 0.049, and 0.043 per person-year in the low, medium, and high MedDiet adherence groups, respectively). Compared with low MedDiet adherence (0 to 3 points), participants with high adherence to the MedDiet (7 to 9 points) had a lower risk for ORC (hazard ratio, 0.94). A similar inverse association was seen for participants with medium adherence (4 to 6 points) compared with low adherence.
"Our mediation analysis did not show waist-to-hip ratio or body mass index as mediators between MedDiet and ORC risk, possibly due to the low prevalence of obesity in our cohort and the distinct contribution of general versus abdominal obesity to metabolic disruptions," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Cancer Survival Lower in Rural Areas
WEDNESDAY, Oct. 1, 2025 -- Five-year cancer survival rates for each stage of cancer (localized, regional, and distant) is lower in nonmetropolitan areas for Black and White...
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
WEDNESDAY, Oct. 1, 2025 -- People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems compared with patients treated...
Patients With Extreme Obesity Face Limitations to Accessing Specialty Care
TUESDAY, Sept. 30, 2025 -- Patients weighing more than 450 lb face considerable limitations when attempting to access specialty care, according to a research letter published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.